神经认知型长新冠综合征的神经心理学特征与脑葡萄糖代谢
研究前瞻性纳入31例PCR确诊新冠后神经认知症状持续超过3个月的门诊患者,采用神经心理学测试组套评估认知,其中14例行18F-FDG PET。患者自述注意力、记忆、多任务能力受损常见,但组平均认知测试无损害,仅个别患者存在视觉记忆等域缺陷;PET亚组脑区葡萄糖代谢无显著改变。
要点
- 长新冠患者自述认知症状普遍,部分无法恢复工作或独立生活。
- 神经心理学测试组平均无损害,仅少数个体存在视觉记忆等域缺陷。
- 18F-FDG PET亚组未见脑区葡萄糖代谢显著改变。
核心结论
- 长新冠患者自述认知症状普遍且影响工作能力,但约感染后6个月时认知测试仅个别患者存在轻度损害,功能影像未见明显病理改变。
- 该结果与既往亚急性COVID-19患者表现明显不同,提示长新冠神经认知症状的神经元机制可能不同,或与疲劳高发相关。
研究设计与样本
- 前瞻性纳入2020年6月16日至2021年1月29日期间因神经认知症状持续超过3个月就诊的PCR确诊COVID-19门诊患者31例,年龄53.6±2.0岁,距PCR阳性202±58天。
- 所有患者接受神经心理学测试组套评估,其中14/31例接受脑18F-FDG PET显像。
主要发现
- 31/31例自述注意力、记忆和多任务能力受损,27/31例存在找词困难,24/31例有疲劳。
- 各认知域组平均结果无损害,但个体水平缺陷(z分数<-1.5)主要见于视觉记忆域(7/31例),其他域≤2/31例。
- 蒙特利尔认知评估平均27/30分,高于认知损害检出界值(<26分),但9/31例得分略低于该水平(23-25分)。
- 接受18F-FDG PET的亚组中,未发现脑区葡萄糖代谢显著改变。
关键数值与推荐
- 神经心理学测试个体水平缺陷定义为z分数<-1.5,视觉记忆域7/31例存在缺陷,其他域≤2/31例。
- 蒙特利尔认知评估认知损害检出界值为<26分,本组平均27/30分,9/31例得分为23-25分。
临床怎么用
- 对长新冠神经认知症状患者,应将客观神经心理学测试与自述症状结合评估,避免仅凭主观症状判断认知损害。
- 18F-FDG PET在长新冠神经认知症状患者中未见显著代谢改变,不作为常规诊断依据。
局限性
- 仅14/31例患者接受18F-FDG PET,影像亚组样本量有限。
- 研究为单中心前瞻性观察,未设健康对照或亚急性COVID-19对照。
- 认知损害仅在个体水平轻度存在,组平均结果可能掩盖异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
During the coronavirus disease 2019 (COVID-19) pandemic, Long COVID syndrome, which impairs patients through cognitive deficits, fatigue, and exhaustion, has become increasingly relevant. Its underlying pathophysiology, however, is unknown. In this study, we assessed cognitive profiles and regional cerebral glucose metabolism as a biomarker of neuronal function in outpatients with long-term neurocognitive symptoms after COVID-19. Methods: Outpatients seeking neurologic counseling with neurocognitive symptoms persisting for more than 3 mo after polymerase chain reaction (PCR)-confirmed COVID-19 were included prospectively between June 16, 2020, and January 29, 2021. Patients (n = 31; age, 53.6 ± 2.0 y) in the long-term phase after COVID-19 (202 ± 58 d after positive PCR) were assessed with a neuropsychologic test battery. Cerebral 18F-FDG PET imaging was performed in 14 of 31 patients. Results: Patients self-reported impaired attention, memory, and multitasking abilities (31/31), word-finding difficulties (27/31), and fatigue (24/31). Twelve of 31 patients could not return to the previous level of independence/employment. For all cognitive domains, average group results of the neuropsychologic test battery showed no impairment, but deficits (z score < -1.5) were present on a single-patient level mainly in the domain of visual memory (in 7/31; other domains ≤ 2/31). Mean Montreal Cognitive Assessment performance (27/30 points) was above the cutoff value for detection of cognitive impairment (<26 points), although 9 of 31 patients performed slightly below this level (23-25 points). In the subgroup of patients who underwent 18F-FDG PET, we found no significant changes of regional cerebral glucose metabolism. Conclusion: Long COVID patients self-report uniform symptoms hampering their ability to work in a relevant fraction. However, cognitive testing showed minor impairments only on a single-patient level approximately 6 mo after the infection, whereas functional imaging revealed no distinct pathologic changes. This clearly deviates from previous findings in subacute COVID-19 patients, suggesting that underlying neuronal causes are different and possibly related to the high prevalence of fatigue.
引用
- Dressing A, Bormann T, Blazhenets G, et al. Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome. J Nucl Med. 2021. PMID: 34649946. doi:10.2967/jnumed.121.262677
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。